Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

NCT00295607 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
Liver Transplantation

Interventions

DRUG: Tacrolimus
DRUG: steroids, monoclonal anti-IL2R antibody

Sponsor

Astellas Pharma Inc